Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in J Invest Dermatol Retrieve available abstracts of 105 articles: HTML format

Single Articles

September 2026
1. HUANG KR, Chang NW, Tai KY, Lin JD, et al
   Contact hypersensitivity promotes hair regeneration through SPP1-secreting macrophages.
   J Invest Dermatol. 2026 Sep 11:S0022-202X(26)02813.
   PubMed     Abstract available
   
   
   
2. BERNA-RICO E, Neria F, Gomez-de la Fuente E, Perez-Garcia B, et al
   Blood proteomics links systemic inflammation with early atherosclerosis in moderate-to-severe atopic dermatitis.
   J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02743.
   PubMed     Abstract available
   
   
   
3. ASLANIAN FP, Halioua B, Tan J, Gu C, et al
   Real-Life Performance of the Dermatology Long-Term Life Impact Measure (DLLIM) in Atopic Dermatitis: An International Study of 15,450 Patients.
   J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02748.
   PubMed    
   
   
   August 2026
4. NORGAARD HAVE MK, Port H, Frolunde AS, Skovsgard CH, et al
   Basement membrane remodeling biomarkers are modulated and reflect treatment response to JAK inhibitors in patients with atopic dermatitis - results from two longitudinal clinical studies.
   J Invest Dermatol. 2026 Aug 18:S0022-202X(26)02741.
   PubMed    
   
   
   
5. NOLDEN K, Shi Y, Batista VS, Bunick CG, et al
   Molecular differentiation of OX40- and OX40L-targeted biologics using AlphaFold3 and molecular dynamics simulations.
   J Invest Dermatol. 2026;146:2267-2279.
   PubMed     Abstract available
   
   
   July 2026
6. WHEELER JJ, Mishra SK
   Divergent roles of TRPV1 and neuropeptides in mouse model of atopic dermatitis.
   J Invest Dermatol. 2026 Jul 30:S0022-202X(26)02718.
   PubMed    
   
   
   
7. BOUAYADI S, Arbey E, Raynaud E, Avila J, et al
   PHYTOCERAMIDES AND 6-HYDROXYCERAMIDES DEFICIENCY CORRELATES WITH BARRIER FUNCTION ALTERATION IN ATOPIC DERMATITIS SKIN.
   J Invest Dermatol. 2026 Jul 21:S0022-202X(26)02681.
   PubMed    
   
   
   
8. CHOI M, Jang H, Lee SM, Jeong SK, et al
   Stratum corneum metabolomics suggests a subclinical biochemical state in non-lesional skin in atopic dermatitis.
   J Invest Dermatol. 2026 Jul 21:S0022-202X(26)02679.
   PubMed    
   
   
   
9. QUAN I, Carstens LY, Lio P
   Association Between Household Endotoxin Exposure and Atopic Dermatitis: A Cross-Sectional U.S.-Based Population Study.
   J Invest Dermatol. 2026 Jul 11:S0022-202X(26)02670.
   PubMed    
   
   
   
10. FONFARA M, Stolzl D, Hartmann J, Harder I, et al
    Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.
    J Invest Dermatol. 2026 Jul 7:S0022-202X(26)02663.
    PubMed     Abstract available
    
    
    
11. HE T, Wang Y, Yu G, Dong E, et al
    Myeloid-driven inflammation highlights ADGRE2 as a biomarker in prurigo nodularis: Integrated multiomics analysis.
    J Invest Dermatol. 2026;146:1918-1929.
    PubMed     Abstract available
    
    
    June 2026
12. ARMSTRONG AW, Roberts AM, Kostandy G, Choudhury F, et al
    Impact of Online vs In-Person Management of Atopic Dermatitis on Quality of Life and Access to Care: A Randomized Controlled Trial.
    J Invest Dermatol. 2026 Jun 26:S0022-202X(26)02656.
    PubMed     Abstract available
    
    
    
13. ZHOU T, Geng S
    Breaking the mast cell-T helper 2 axis in atopic dermatitis: Insights from oral MRGPRX2 antagonist.
    J Invest Dermatol. 2026 Jun 17:S0022-202X(26)01263.
    PubMed    
    
    
    
14. SACKNOVITZ Y, Ma R, Zhou MH, Kent J, et al
    Serum proteomic and single-cell transcriptomic profiling reveals immunoproteomic features distinguishing early-stage mycosis fungoides from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 10:S0022-202X(26)02599.
    PubMed    
    
    
    
15. ZHAO Q, Leguina-Ruzzi A, Tominaga M, Kamata Y, et al
    Psychological stress delays inflammatory resolution and promotes sustained sensory sensitization during recovery from atopic dermatitis.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)02596.
    PubMed    
    
    
    
16. RIEBELMANN J, Schittek B
    The role of neutrophils and neutrophil extracellular traps in Staphylococcus aureus colonization in healthy and inflamed skin.
    J Invest Dermatol. 2026 Jun 9:S0022-202X(26)01050.
    PubMed     Abstract available
    
    
    
17. PETERS RHW, Smits JPH, van den Bogaard EH, Kelemen E, et al
    Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
    J Invest Dermatol. 2026 Jun 5:S0022-202X(26)01200.
    PubMed     Abstract available
    
    
    
18. YANG K, Mircescu A, Okusanya D, Mohsen S, et al
    Understanding the Atopic Dermatitis-Psoriasis Phenotypic Switch Through a Pharmacovigilance-Based Approach.
    J Invest Dermatol. 2026 Jun 1:S0022-202X(26)01267.
    PubMed    
    
    
    May 2026
19. STRATIGOS A, Steinhoff M, Luger T, Tan J, et al
    Impact of atopic dermatitis on education and career choices: the Scars of Life international study.
    J Invest Dermatol. 2026 May 28:S0022-202X(26)01041.
    PubMed    
    
    
    
20. YEUNG K, Weber JF, Stegenborg-Grathwohl SM, Hu T, et al
    Anakinra alters epidermal tissue-resident memory T cell profiles but fails to reduce clinical responses upon nickel re-challenge in individuals with nickel allergy.
    J Invest Dermatol. 2026 May 8:S0022-202X(26)01190.
    PubMed    
    
    
    
21. CHEN R, Miltner LA, Loman L, Schuttelaar MLA, et al
    ADULTS WITH ATOPIC DERMATITIS AND ATOPIC MULTIMORBIDITY EXPERIENCE IMPAIRED SLEEP QUALITY.
    J Invest Dermatol. 2026 May 7:S0022-202X(26)01188.
    PubMed    
    
    
    
22. WOLLAM J, Solomon M, Villescaz C, Srinivasan S, et al
    MRGPRX2 Antagonist Treatment Prevents Inflammation and Disease in a Mouse Model of Atopic Dermatitis.
    J Invest Dermatol. 2026 May 4:S0022-202X(26)01182.
    PubMed     Abstract available
    
    
    April 2026
23. WITTE F, Wiegmann H, Teitge E, Westmeier J, et al
    Evaluation of Itch Intensity Scales in Atopic Dermatitis: Differential Measurement Properties and Associations with Relevant Cytokines.
    J Invest Dermatol. 2026 Apr 20:S0022-202X(26)01046.
    PubMed     Abstract available
    
    
    March 2026
24. TRUJILLO A, Munguia N, Craig N, Wilkes R, et al
    Genome-wide Study Identifies a Locus Associated with Atopic Dermatitis Severity in a Canine Model.
    J Invest Dermatol. 2026 Mar 25:S0022-202X(26)01000.
    PubMed    
    
    
    
25. JIANG W, Xie X, Yang S, Xu R, et al
    Basophil Activity in Atopic Dermatitis: Distinct Immunomodulatory Roles of Dupilumab and Abrocitinib.
    J Invest Dermatol. 2026 Mar 9:S0022-202X(26)00746.
    PubMed     Abstract available
    
    
    
26. OTROFANOWEI E, Ahogo KC, Atadokpede F, Bahloul E, et al
    Accessibility And Affordability Of Emollients In The Management Of Atopic Dermatitis (AD) In Africa.
    J Invest Dermatol. 2026 Mar 2:S0022-202X(26)00137.
    PubMed     Abstract available
    
    
    February 2026
27. XIAO F, Wu R, Wu N, Xie Y, et al
    Fat mass and obesity-associated (FTO)/SOCS6-m(6)A axis epigenetic modification links obesity to atopic dermatitis by regulating keratinocyte function.
    J Invest Dermatol. 2026 Feb 3:S0022-202X(26)00068.
    PubMed     Abstract available
    
    
    January 2026
28. DUBRAC S, Combarros D, Olah A, Cadiergues MC, et al
    Recommendations on in vitro models for canine atopic dermatitis.
    J Invest Dermatol. 2026 Jan 20:S0022-202X(25)03668.
    PubMed    
    
    
    December 2025
29. KIM KC, Lee JH
    Harnessing cannabidiol: an approach to attenuating Th2 inflammation via JAK/STAT signaling and modulating CB2 receptor in atopic dermatitis.
    J Invest Dermatol. 2025 Dec 15:S0022-202X(25)03640.
    PubMed    
    
    
    November 2025
30. BISSONNETTE R, Saint-Cyr Proulx E, Correa da Rosa J, Estrada Y, et al
    Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers.
    J Invest Dermatol. 2025 Nov 18:S0022-202X(25)03550.
    PubMed     Abstract available
    
    
    
31. KAWAKAMI E
    Dynamic Network Biomarker Analysis Reveals Predisease State in Atopic Dermatitis.
    J Invest Dermatol. 2025 Nov 11:S0022-202X(25)03458.
    PubMed    
    
    
    
32. PARK JJ, Richards D, Tseng PH, Ebata T, et al
    Methods to Validate Digital Health Technologies for Dermatology.
    J Invest Dermatol. 2025;145:2668-2675.
    PubMed     Abstract available
    
    
    October 2025
33. MISERY L, Talagas M, Le Gall-Ianotto C
    Dupilumab's Effects on Itch Sensitization in Atopic Dermatitis.
    J Invest Dermatol. 2025 Oct 21:S0022-202X(25)02477.
    PubMed    
    
    
    September 2025
34. SENSUI T, Iwasaki K, Aihara K
    Identification of Pre-Disease State in NC/Nga Mice with Atopic Dermatitis-Like Symptoms Using Dynamical Network Biomarkers.
    J Invest Dermatol. 2025 Sep 22:S0022-202X(25)02436.
    PubMed     Abstract available
    
    
    
35. SCHNEIDERMAN M
    Association of Adult Atopic Dermatitis and Repetitive Strain Injury: A U.S. Population-Based Study.
    J Invest Dermatol. 2025 Sep 19:S0022-202X(25)02435.
    PubMed    
    
    
    
36. BASH GN, Baghoomian W, Seshadri R, Latour E, et al
    Aberrant Epidermal Innervation in Adults with Atopic Dermatitis is Restored Following Dupilumab Treatment.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02424.
    PubMed    
    
    
    
37. GALLO RL
    Drugs and Bugs in Atopic Dermatitis: Benefits to the Skin Microbiome from Targeted Immunotherapies.
    J Invest Dermatol. 2025 Sep 10:S0022-202X(25)02325.
    PubMed    
    
    
    
38. BURSHTEIN J, Bunick CG, Vleugels RA, Armstrong AW, et al
    Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy.
    J Invest Dermatol. 2025 Sep 6:S0022-202X(25)02338.
    PubMed    
    
    
    
39. KROGH NS, Prieto-Merino D, Coker B, Birkner T, et al
    Implementing Federated Analysis using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
    J Invest Dermatol. 2025 Sep 3:S0022-202X(25)02407.
    PubMed     Abstract available
    
    
    
40. WANG Q, Qiu Q, Sun H, Liu Y, et al
    Distinct Comorbidity Clusters and Their Genetic Associations with Atopic Dermatitis in Middle-Aged and Elderly Adults.
    J Invest Dermatol. 2025 Sep 2:S0022-202X(25)02404.
    PubMed    
    
    
    August 2025
41. WIEGMANN H, Witte F, Renkhold L, Westmeier J, et al
    Cutaneous neuroanatomical and cellular response to dupilumab treatment in atopic dermatitis.
    J Invest Dermatol. 2025 Aug 22:S0022-202X(25)02353.
    PubMed     Abstract available
    
    
    
42. BECKER SL, Bash GN, Begolka WS, Wallace-Hood T, et al
    Improving the quality of atopic dermatitis epidemiological research in the United States- A systematic review of disease definitions and related content in national surveys.
    J Invest Dermatol. 2025 Aug 13:S0022-202X(25)02337.
    PubMed     Abstract available
    
    
    
43. BUNICK CG
    Biologic Therapies Targeting Type 2 Signaling in Atopic Dermatitis: A Comparative Review of Structural and Thermodynamic Differences in Mechanism of Action.
    J Invest Dermatol. 2025 Aug 5:S0022-202X(25)02203.
    PubMed     Abstract available
    
    
    
44. SHOBNAM N, Ratley G, Saksena S, Yadav M, et al
    Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD.
    J Invest Dermatol. 2025;145:1953-1968.
    PubMed     Abstract available
    
    
    July 2025
45. THOMOVA T, Jedlickova H, Bohm J, Holochova P, et al
    EFFECT OF SYSTEMIC THERAPIES ON SKIN BACTERIOME IN PATIENTS WITH ATOPIC DERMATITIS: A PILOT PROSPECTIVE STUDY.
    J Invest Dermatol. 2025 Jul 28:S0022-202X(25)02307.
    PubMed     Abstract available
    
    
    
46. BAZZINI C, Bertschi NL, Steck O, Luther F, et al
    Human T Helper 9 Cells Rely on Peroxisome Proliferator-Activated Receptor-gamma-Mediated Cystine Uptake to Prevent Lipid Peroxidation and Bioenergetic Failure.
    J Invest Dermatol. 2025;145:1693-1705.
    PubMed     Abstract available
    
    
    June 2025
47. BUNICK CG, Armstrong AW, Grada A, Soliman AM, et al
    The Epidemiology of Atopic Dermatitis Among Adults and Adolescents with Alopecia Areata in the United States.
    J Invest Dermatol. 2025 Jun 26:S0022-202X(25)02236.
    PubMed     Abstract available
    
    
    
48. GELLER S
    Cutaneous T-Cell Lymphoma after Dupilumab Treatment in Patients with Atopic Dermatitis: A Response Letter to James et al.
    J Invest Dermatol. 2025 Jun 24:S0022-202X(25)00542.
    PubMed    
    
    
    
49. WANG J, Ho M, Bunick CG
    Chemical, Biochemical, and Structural Similarities and Differences of Dermatological cAMP Phosphodiesterase-IV Inhibitors.
    J Invest Dermatol. 2025;145:1471-1488.
    PubMed     Abstract available
    
    
    May 2025
50. OCHIAI S, Larson AR, Mayer JU, Yang J, et al
    Allergic Skin Inflammation Drives IL-4-Dependent Differentiation of Dermal CD11b-low Dendritic Cells.
    J Invest Dermatol. 2025 May 28:S0022-202X(25)00536.
    PubMed     Abstract available
    
    
    
51. FUNCH AB, Weber JF, Mraz V, Kongsbak-Wismann M, et al
    CD8(+) Skin-Resident Memory T Cells Require TCR Signaling for their Persistence in a Mouse Model of Allergic Contact Dermatitis.
    J Invest Dermatol. 2025 May 27:S0022-202X(25)00529.
    PubMed     Abstract available
    
    
    
52. ZHANG J, Yu Y, Zhao P, Yuan L, et al
    Clinical characteristics of hand eczema and its association with atopic dermatitis in the Chinese population: A multicenter cross-sectional study.
    J Invest Dermatol. 2025 May 19:S0022-202X(25)00486.
    PubMed     Abstract available
    
    
    
53. LEE M, Mikol V, Truong V, Attieh E, et al
    Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2a Trial.
    J Invest Dermatol. 2025 May 5:S0022-202X(25)00462.
    PubMed    
    
    
    
54. FAHMY LM, Adeuyan OO, de Jong A
    CD1a and Lipids as Mediators of T Cell Activation in the Skin.
    J Invest Dermatol. 2025 May 3:S0022-202X(25)00383.
    PubMed     Abstract available
    
    
    April 2025
55. STAMATAS GN, Insel R, Sorensen N, Palleja A, et al
    Shifts in Infant Skin Microbiome at 2 Months following Short-term Emollient Use from Birth are Associated with Reduced Prevalence of Atopic Dermatitis at 12 Months in a High-Risk Cohort.
    J Invest Dermatol. 2025 Apr 7:S0022-202X(25)00380.
    PubMed    
    
    
    March 2025
56. ZHANG H, Tang S, Chen X, Wang M, et al
    Association Between Emotional Distress and Atopic Dermatitis: A Cross-Sectional Study.
    J Invest Dermatol. 2025 Mar 24:S0022-202X(25)00365.
    PubMed    
    
    
    
57. LEBTIG M, Peschel A, Kretschmer D
    Role of Formyl Peptide Receptor 2 and Toll-Like Receptor 2 in Skin Barrier Function and Atopic Dermatitis.
    J Invest Dermatol. 2025 Mar 9:S0022-202X(25)00100.
    PubMed     Abstract available
    
    
    
58. WANG Y, Yin H, Li Z, Wu H, et al
    Blood transcriptome signature as indicator and predictor for efficacy of abrocitinib in treatment of atopic dermatitis.
    J Invest Dermatol. 2025 Mar 7:S0022-202X(25)00311.
    PubMed     Abstract available
    
    
    February 2025
59. INGEN-HOUSZ-ORO S, Matei I, Gaillet A, Gueudry J, et al
    Diagnosing and Managing Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017-2023.
    J Invest Dermatol. 2025 Feb 27:S0022-202X(25)00078.
    PubMed     Abstract available
    
    
    
60. KAMP E, Ascott A, George SMC
    Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.
    J Invest Dermatol. 2025 Feb 24:S0022-202X(25)00099.
    PubMed     Abstract available
    
    
    January 2025
61. HU J, Zhao Q, Che D, Peng B, et al
    Epidermal Mechanical Scratching-Induced ROS Exacerbates the Itch-Scratch Cycle via TRPA1 Activation on Mast Cells in Atopic Dermatitis.
    J Invest Dermatol. 2025 Jan 30:S0022-202X(25)00076.
    PubMed     Abstract available
    
    
    
62. ABUABARA K, Kidd SA, Ye M, Tully J, et al
    The impact of childhood stressful life events on atopic dermatitis disease activity and severity.
    J Invest Dermatol. 2025 Jan 28:S0022-202X(25)00081.
    PubMed     Abstract available
    
    
    
63. GOHARA Y, Kinoshita R, Tomonobu N, Jiang F, et al
    An S100A8/A9 neutralizing antibody potently ameliorates contact hypersensitivity and atopic dermatitis symptoms.
    J Invest Dermatol. 2025 Jan 21:S0022-202X(25)00029.
    PubMed     Abstract available
    
    
    
64. BRIOT J, Pons C, Foucher A, Goudouneche D, et al
    Prolyl Endopeptidase Is Involved in Filaggrinolysis and Cornification.
    J Invest Dermatol. 2025;145:98-108.
    PubMed     Abstract available
    
    
    December 2024
65. AZEEM M, Helal M, Klein-Hessling S, Serfling E, et al
    NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03036.
    PubMed     Abstract available
    
    
    
66. TANDON R, Harder I, Stolzl D, Hubenthal M, et al
    Tralokinumab Treatment of Atopic Dermatits Induces A Progressive Transcriptomic Response.
    J Invest Dermatol. 2024 Dec 27:S0022-202X(24)03035.
    PubMed     Abstract available
    
    
    
67. ISKANDAR RJ, Drucker AM
    A Framework to Efficiently Monitor the Comparative Safety of Systemic Immunomodulatory Medications for Atopic Dermatitis.
    J Invest Dermatol. 2024 Dec 20:S0022-202X(24)02961.
    PubMed    
    
    
    
68. BRAHIMI N, Croitoru D, Saidoune F, Zabihi H, et al
    From Viral Infection to Skin Affliction: Unveiling Mechanisms of Cutaneous Manifestations in COVID-19 and Post-COVID Conditions.
    J Invest Dermatol. 2024 Dec 10:S0022-202X(24)01883.
    PubMed     Abstract available
    
    
    November 2024
69. YEW YW, Loh M, Brown SJ
    Understanding Atopic Dermatitis in Asian and European Population Cohorts Using Complementary Omics Techniques.
    J Invest Dermatol. 2024 Nov 5:S0022-202X(24)02171.
    PubMed     Abstract available
    
    
    
70. MASISON J, Lehmann HP, Wan J
    Utilization of Computable Phenotypes in Electronic Health Record Research: A Review and Case Study in Atopic Dermatitis.
    J Invest Dermatol. 2024 Nov 1:S0022-202X(24)02103.
    PubMed     Abstract available
    
    
    October 2024
71. DAI X, Mizukami Y, Watanabe K, Tsuda T, et al
    Trehalose prevents IL-4/IL-13-induced skin barrier impairment by suppressing IL-33 expression and increasing Nrf2 activation in human keratinocytes in vitro.
    J Invest Dermatol. 2024 Oct 7:S0022-202X(24)02175.
    PubMed     Abstract available
    
    
    
72. SCHNEEWEISS MC, Glynn RJ, Wyss R, Anand P, et al
    A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice.
    J Invest Dermatol. 2024 Oct 1:S0022-202X(24)02169.
    PubMed     Abstract available
    
    
    September 2024
73. FRISOLI ML, Ko WC, Martinez N, Afshari K, et al
    Single cell RNA-sequencing reveals molecular signatures that distinguish allergic from irritant contact dermatitis.
    J Invest Dermatol. 2024 Sep 26:S0022-202X(24)02152.
    PubMed     Abstract available
    
    
    
74. CASSAGNE M, Galiacy S, Kychygina A, Chapotot E, et al
    Superficial Conjunctival Cells from Dupilumab-treated Atopic Dermatitis Patients with Ocular Adverse Events Display a Transcriptomic Psoriasis Signature.
    J Invest Dermatol. 2024 Sep 19:S0022-202X(24)02102.
    PubMed     Abstract available
    
    
    August 2024
75. LI Y, Chen W, Zhu X, Mei H, et al
    Neuronal BST2: A Pruritic Mediator alongside Protease-Activated Receptor 2 in the IL-27-Driven Itch Pathway.
    J Invest Dermatol. 2024;144:1829-1842.
    PubMed     Abstract available
    
    
    June 2024
76. HUANG KR, Mai-Yi Fan S, Tai KY, Lin JD, et al
    Essential role of macrophages in contact hypersensitivity-induced hair regeneration.
    J Invest Dermatol. 2024 Jun 25:S0022-202X(24)01739.
    PubMed    
    
    
    
77. SHIOHARA T, Mizukawa Y
    The Neglected Beneficial Role of Sweat in Atopic Dermatitis Is Spotlighted at Last.
    J Invest Dermatol. 2024 Jun 22:S0022-202X(24)00381.
    PubMed    
    
    
    
78. MA X, Zhao H, Song JK, Zhang Z, et al
    Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence.
    J Invest Dermatol. 2024 Jun 13:S0022-202X(24)01735.
    PubMed     Abstract available
    
    
    
79. SHEN S, Sobczyk MK, Paternoster L, Brown SJ, et al
    From GWASs toward Mechanistic Understanding with Case Studies in Dermatogenetics.
    J Invest Dermatol. 2024;144:1189-1199.
    PubMed     Abstract available
    
    
    May 2024
80. SONG Z, Gao M, Li T, Zhang Y, et al
    TRPV3-activated PARP1/AIFM1/MIF axis through oxidative stress contributes to atopic dermatitis.
    J Invest Dermatol. 2024 May 30:S0022-202X(24)00384.
    PubMed     Abstract available
    
    
    
81. BORZUTZKY A, Cabalin C
    From Thin to Thick: Weight Gain in Children Feeds the Risk of Atopic Dermatitis.
    J Invest Dermatol. 2024 May 14:S0022-202X(24)00281.
    PubMed    
    
    
    
82. SCHMUTH M, Eckmann S, Moosbrugger-Martinz V, Ortner-Tobider D, et al
    Skin Barrier in Atopic Dermatitis.
    J Invest Dermatol. 2024;144:989-1000.
    PubMed     Abstract available
    
    
    
83. BROWN SJ, Gudjonsson JE
    Halting the Vicious Cycle of Atopic Dermatitis: Empowered by Scientific Understanding.
    J Invest Dermatol. 2024;144:917-918.
    PubMed    
    
    
    April 2024
84. PASANEN A, Sliz E, Huilaja L, Reimann E, et al
    Identifying atopic dermatitis risk loci in 1,094,060 individuals with sub analysis of disease severity and onset.
    J Invest Dermatol. 2024 Apr 23:S0022-202X(24)00285.
    PubMed     Abstract available
    
    
    
85. VAN DEN BRINK NJM, Pardow F, Meesters LD, van Vlijmen-Willems I, et al
    Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
    J Invest Dermatol. 2024 Apr 18:S0022-202X(24)00293.
    PubMed     Abstract available
    
    
    
86. PALLER AS, Scharschmidt TC, Kezic S, Irvine AD, et al
    Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area.
    J Invest Dermatol. 2024 Apr 2:S0022-202X(24)00186.
    PubMed     Abstract available
    
    
    March 2024
87. ARADI P, Kovacs G, Kemecsei E, Molnar K, et al
    Lymphatics-dependent modulation of the sensitization and elicitation phases of contact hypersensitivity.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00261.
    PubMed     Abstract available
    
    
    
88. SAHEB KASHAF S, Kong HH
    Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00082.
    PubMed     Abstract available
    
    
    
89. XIA E, Gaurav A, Noe MH, Mostaghimi A, et al
    Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.
    J Invest Dermatol. 2024 Mar 26:S0022-202X(24)00212.
    PubMed    
    
    
    
90. ISHIMARU H, Nakamoto K, Yamane M, Yamamoto T, et al
    Sweat Protects against Contact Hypersensitivity: Transient Sweat Suppression Compromises Skin Barrier Function in Mice.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00196.
    PubMed     Abstract available
    
    
    
91. 
    WITHDRAWN: Expression of Concern: Zhou et al, Extracellular Vesicles of Commensal Skin Microbiota Alleviate Cutaneous Inflammation in Atopic Dermatitis Mouse Model by Re-Establishing Skin Homeostasis. J Invest Derm doi:10.1016/j.jid.2023.02.023.
    J Invest Dermatol. 2024 Mar 22:S0022-202X(24)00173.
    PubMed     Abstract available
    
    
    
92. DROLL SH, Zhang BJ, Levine MC, Xue C, et al
    CASZ1 is Essential for Skin Epidermal Terminal Differentiation.
    J Invest Dermatol. 2024 Mar 6:S0022-202X(24)00172.
    PubMed     Abstract available
    
    
    
93. ROUSEL J, Mergen C, Schoones JW, Niemeyer-van der Kolk T, et al
    Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis and ichthyosis: results from a systematic review and meta-analysis.
    J Invest Dermatol. 2024 Mar 4:S0022-202X(24)00168.
    PubMed    
    
    
    
94. DAS M, Mukherjee S, Geha RS
    Phosphodiesterase 4 Inhibitors, Basophils, and Atopic Dermatitis.
    J Invest Dermatol. 2024 Mar 3:S0022-202X(24)00096.
    PubMed    
    
    
    
95. BRAHIMI N, Piguet V
    Autophagy during Severe Acute Respiratory Syndrome Coronavirus 2 Induced Leukocytoclastic Vasculitis: New Insights.
    J Invest Dermatol. 2024;144:441-443.
    PubMed    
    
    
    
96. BETTUZZI T, Hoisnard L, Beytout Q, Ingen-Housz-Oro S, et al
    Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database.
    J Invest Dermatol. 2024;144:708-710.
    PubMed    
    
    
    
97. WANG X, Mao D, Jia J, Zhang J, et al
    Benvitimod Inhibits IL-4- and IL-13-Induced Tight Junction Impairment by Activating AHR/ARNT Pathway and Inhibiting STAT6 Phosphorylation in Human Keratinocytes.
    J Invest Dermatol. 2024;144:509-519.
    PubMed     Abstract available
    
    
    February 2024
98. GALLO RL, Horswill AR
    Staphylococcus aureus: The Bug Behind the Itch in Atopic Dermatitis.
    J Invest Dermatol. 2024 Feb 29:S0022-202X(24)00002.
    PubMed     Abstract available
    
    
    
99. MUKHOPADHYAY S, Brown SJ
    FLG Knockdown-Related Skin-Lung Crosstalk Biologically Underpins an Filaggrin-Related Childhood Asthma Subtype.
    J Invest Dermatol. 2024 Feb 16:S0022-202X(24)00027.
    PubMed    
    
    
    January 2024
100. YEO H, Ahn SS, Ou S, Yun SJ, et al
     The EGR1-ARTN axis in keratinocytes enhances the innervation of epidermal sensory neurons during skin inflammation induced by house dust mite extract from Dermatophagoides farinae.
     J Invest Dermatol. 2024 Jan 30:S0022-202X(24)00090.
     PubMed     Abstract available
     
     
     
101. BIER K, Senajova Z, Henrion F, Wang Y, et al
     Interleukin-26 potentiates type 2 skin inflammation in presence of interleukin-1beta.
     J Invest Dermatol. 2024 Jan 16:S0022-202X(24)00017.
     PubMed     Abstract available
     
     
     November 2023
102. ZHANG W, Akhtar N, Zhao J, Spandau DF, et al
     Fibronectin promotes wound healing in an atopic human skin xenografting model.
     J Invest Dermatol. 2023 Nov 30:S0022-202X(23)03118.
     PubMed    
     
     
     
103. YU J, Song P, Bai Y, Dang E, et al
     CD36-SREBP1 Axis Mediates TSLP Production in Obesity-Exacerbated Atopic Dermatitis.
     J Invest Dermatol. 2023;143:2153-2162.
     PubMed     Abstract available
     
     
     
104. LIN FJ, Huang YH, Tsao CH, Hsieh WC, et al
     Galectin-12 Regulates Immune Responses in the Skin through Sebaceous Glands.
     J Invest Dermatol. 2023;143:2120-2131.
     PubMed     Abstract available
     
     
     October 2023
105. FUKUNAGA K, Tsukagoshi E, Kurata M, Mizukawa Y, et al
     Differential effects of HLA-B*15:11 and HLA-A*31:01 on carbamazepine-induced cutaneous adverse reactions.
     J Invest Dermatol. 2023 Oct 21:S0022-202X(23)02972.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum